US Patent Issued to UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION, THE ASAN FOUNDATION on Nov. 4 for "Biomarker cereblon for diagnosing hepatocellular carcinoma, and novel monoclonal antibody specific thereto" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,461,103, issued on Nov. 4, was assigned to UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION (Ulsan, South Korea) and THE ASAN FOUNDATION (Seoul, South Korea).

"Biomarker cereblon for diagnosing hepatocellular carcinoma, and novel monoclonal antibody specific thereto" was invented by Kyung Jin Lee (Hanam-si, South Korea) and Sin Hwang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are the use of cereblon (CRBN) as a biomarker for diagnosis of hepatocellular carcinoma and novel monoclonal antibodies specific to CRBN. More specifically, provided are a composition and a kit for diagnosing or predicting the prognosis of hep...